Fuller & Thaler Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $122M | Buy |
230,555
+156,900
| +213% | +$72.4M | 0.33% | 103 |
|
|
2026
Q1 | $35.4M | Sell |
73,655
-3,222
| -4% | -$1.65M | 0.12% | 230 |
|
|
2025
Q4 | $43.2M | Buy |
76,877
+3,847
| +5% | +$2.18M | 0.15% | 216 |
|
|
2025
Q3 | $37.5M | Buy |
73,030
+1,154
| +2% | +$504K | 0.13% | 225 |
|
|
2025
Q2 | $22.6M | Sell |
71,876
-12,126
| -14% | -$3.64M | 0.08% | 251 |
|
|
2025
Q1 | $25.6M | Sell |
84,002
-17,729
| -17% | -$5.96M | 0.1% | 241 |
|
|
2024
Q4 | $33.8M | Sell |
101,731
-128,668
| -56% | -$43.6M | 0.13% | 227 |
|
|
2024
Q3 | $76.9M | Sell |
230,399
-85,851
| -27% | -$32.6M | 0.3% | 112 |
|
|
2024
Q2 | $130M | Sell |
316,250
-1,454
| -0.5% | -$576K | 0.56% | 49 |
|
|
2024
Q1 | $128M | Sell |
317,704
-127,034
| -29% | -$44.7M | 0.56% | 56 |
|
|
2023
Q4 | $136M | Sell |
444,738
-193,716
| -30% | -$52.3M | 0.69% | 38 |
|
|
2023
Q3 | $155M | Sell |
638,454
-304,816
| -32% | -$78M | 0.89% | 21 |
|
|
2023
Q2 | $227M | Buy |
943,270
+3,325
| +0.4% | +$691K | 1.29% | 11 |
|
|
2023
Q1 | $177M | Buy |
939,945
+1,747
| +0.2% | +$361K | 1.02% | 17 |
|
|
2022
Q4 | $199M | Buy |
938,198
+124,314
| +15% | +$24.8M | 1.27% | 12 |
|
|
2022
Q3 | $128M | Buy |
813,884
+333,184
| +69% | +$53.2M | 0.92% | 23 |
|
|
2022
Q2 | $71.9M | Sell |
480,700
-13,791
| -3% | -$2M | 0.5% | 69 |
|
|
2022
Q1 | $80.9M | Sell |
494,491
-956
| -0.2% | -$158K | 0.48% | 70 |
|
|
2021
Q4 | $108M | Buy |
495,447
+15,064
| +3% | +$3.15M | 0.63% | 47 |
|
|
2021
Q3 | $90.9M | Buy |
480,383
+65,218
| +16% | +$11.9M | 0.59% | 54 |
|
|
2021
Q2 | $73.3M | Buy |
415,165
+10,862
| +3% | +$1.87M | 0.48% | 71 |
|
|
2021
Q1 | $66.3M | Sell |
404,303
-160,248
| -28% | -$24.5M | 0.47% | 74 |
|
|
2020
Q4 | $78.6M | Sell |
564,551
-305,844
| -35% | -$38.5M | 0.73% | 37 |
|
|
2020
Q3 | $97.3M | Buy |
870,395
+7,741
| +0.9% | +$895K | 1.23% | 13 |
|
|
2020
Q2 | $80.2M | Buy |
862,654
+135,838
| +19% | +$11.6M | 1.05% | 18 |
|
|
2020
Q1 | $53.3M | Buy |
726,816
+157,308
| +28% | +$13.7M | 0.9% | 29 |
|
|
2019
Q4 | $47.9M | Buy |
569,508
+19,699
| +4% | +$1.52M | 0.53% | 66 |
|
|
2019
Q3 | $46.2M | Sell |
549,809
-5,883
| -1% | -$445K | 0.55% | 66 |
|
|
2019
Q2 | $36.4M | Buy |
555,692
+227,991
| +70% | +$13.1M | 0.42% | 84 |
|
|
2019
Q1 | $19.3M | Sell |
327,701
-470,813
| -59% | -$28.1M | 0.24% | 114 |
|
|
2018
Q4 | $42.3M | Buy |
798,514
+176,052
| +28% | +$9.66M | 0.61% | 58 |
|
|
2018
Q3 | $37.3M | Buy |
+622,462
| New | +$34M | 0.39% | 87 |
|
Other funds holding MEDP
WA
Fuller & Thaler Asset Management's MEDP Position: Q2 2026 in Review
Fuller & Thaler Asset Management increased its Medpace (MEDP) stake by 213% in Q2 2026, buying an estimated $72.4M and bringing the position to 230,555 shares worth $122M. The position accounts for 0.33% of the portfolio, ranked #103.
Fuller & Thaler Asset Management first reported a position in MEDP in Q3 2018 and has held it in 32 quarters since. The position peaked at $227M in Q2 2023. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Fuller & Thaler Asset Management held 230,555 shares of Medpace worth $122M as of Q2 2026.
- Fuller & Thaler Asset Management bought 156,900 Medpace shares in Q2 2026, an estimated $72.4M.
- Medpace made up 0.33% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #103 holding.
- Fuller & Thaler Asset Management first reported a position in Medpace in Q3 2018 and has held it in 32 quarters since.
- Fuller & Thaler Asset Management's Medpace position peaked at $227M in Q2 2023.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.